Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Aamdal

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma: a multicenter phase II studyG Stoter, S Aamdal, S Rodenhuis, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC Early Clinical Trials GroupS Aamdal, I Wolff, S Kaplan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Acute liver graft rejection after ipilimumab therapyS Dueland, T K Guren, K M Boberg, et al.
Cancer Chemotherapy and Pharmacology|August 21, 2015
A first-in-human phase I and pharmacokinetic study of CP-4126 (CO-101), a nucleoside analogue, in patients with advanced solid tumoursB Venugopal, A Awada, T R J Evans, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1989
Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma. A multicentre phase II studyG Stoter, E Shiloni, S Aamdal, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Zeniplatin in advanced malignant melanoma and renal cancer: phase II studies with unexpected nephrotoxicityS Aamdal, U Bruntsch, J Kerger, et al.
British Journal of Cancer|September 2, 2005
Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patientsL J Mu, J A Kyte, G Kvalheim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1994
Gemcitabine in patients with advanced malignant melanoma or gastric cancer: phase II studies of the EORTC Early Clinical Trials GroupC Sessa, S Aamdal, I Wolff, et al.
Cancer Gene Therapy|May 20, 2006
Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNAJ A Kyte, L Mu, S Aamdal, et al.
British Journal of Cancer|February 1, 1996
Phase II clinical trials with rhizoxin in breast cancer and melanoma. The EORTC Early Clinical Trials GroupA R Hanauske, G Catimel, S Aamdal, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma: a multicenter phase II studyG Stoter, S Aamdal, S Rodenhuis, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC Early Clinical Trials GroupS Aamdal, I Wolff, S Kaplan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Acute liver graft rejection after ipilimumab therapyS Dueland, T K Guren, K M Boberg, et al.
Cancer Chemotherapy and Pharmacology|August 21, 2015
A first-in-human phase I and pharmacokinetic study of CP-4126 (CO-101), a nucleoside analogue, in patients with advanced solid tumoursB Venugopal, A Awada, T R J Evans, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1989
Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma. A multicentre phase II studyG Stoter, E Shiloni, S Aamdal, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Zeniplatin in advanced malignant melanoma and renal cancer: phase II studies with unexpected nephrotoxicityS Aamdal, U Bruntsch, J Kerger, et al.
British Journal of Cancer|September 2, 2005
Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patientsL J Mu, J A Kyte, G Kvalheim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1994
Gemcitabine in patients with advanced malignant melanoma or gastric cancer: phase II studies of the EORTC Early Clinical Trials GroupC Sessa, S Aamdal, I Wolff, et al.
Cancer Gene Therapy|May 20, 2006
Phase I/II trial of melanoma therapy with dendritic cells transfected with autologous tumor-mRNAJ A Kyte, L Mu, S Aamdal, et al.
British Journal of Cancer|February 1, 1996
Phase II clinical trials with rhizoxin in breast cancer and melanoma. The EORTC Early Clinical Trials GroupA R Hanauske, G Catimel, S Aamdal, et al.
Pageof 7